Verma Abhimanyu 4/A
4/A · SOPHiA GENETICS SA · Filed Apr 8, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CTO Abhimanyu Verma Receives RSU Award
What Happened
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS (SOPH), was granted equity on April 2, 2026. The Form 4/A reports two award entries: 82,136 ordinary shares acquired at $0.00 and 119,760 derivative awards (RSUs) acquired at $0.00, for a combined 201,896 share-based awards. The transaction is an award/grant (code A) and involved no cash payment.
Key Details
- Transaction date: April 2, 2026 (reported on an amended Form 4 filed April 8, 2026).
- Awards reported:
- 82,136 ordinary shares @ $0.00 (acquired)
- 119,760 derivative awards (RSUs) @ $0.00 (acquired)
- Total awarded on 4/2/2026: 201,896 share equivalents.
- Shares beneficially owned following the transaction (corrected): 207,949 ordinary shares (per footnote F2; this Form 4/A corrects the Column 5 amount previously reported).
- Vesting/terms:
- F1: RSU grant — 25% vests April 2, 2027; remaining 75% vest in equal quarterly installments through April 2, 2030.
- F3: (separate note in filing) indicates a share option vests 25% April 2, 2027 then in equal monthly installments through April 2, 2030.
- Filing notes: This is an amended Form 4 (filed 2026-04-08) amending the Form 4 filed 2026-04-03 to correct beneficial ownership. No tax-withholding or 10b5-1 plan is indicated on the form.
Context
These entries are grants/awards (not purchases or open-market sales) and therefore reflect compensation/equity incentives subject to multi-year vesting schedules. Derivative RSUs represent contingent rights to receive ordinary shares upon vesting — not immediate marketable shares. The amendment corrects the ownership total but does not change that the awards were granted at $0.00.
Insider Transaction Report
- Award
Ordinary Shares
[F1][F2]2026-04-02+82,136→ 207,949 total - Award
Share Option (Right to Buy)
[F3]2026-04-02+119,760→ 119,760 totalExercise: $5.04Exp: 2036-04-02→ Ordinary Shares (119,760 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030.
- [F2]This Form 4/A amends the Form 4 filed on April 3, 2026 to correct the amount reported in Column 5 (Amount of Securities Beneficially Owned Following Reported Transaction), which was previously reported as 82,136 ordinary shares due to an inadvertent error. The correct amount is 207,949 ordinary shares.
- [F3]The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.